Home » Topics » BioWorld Science

BioWorld Science
RSS

Characterization of novel RORgamma inhibitors for the treatment of autoimmune disease

July 24, 2019

Samus Therapeutics announces the launch of PU-AD clinical program

July 24, 2019

Marinus Pharmaceuticals presents data from Magnolia and Amaryllis phase II studies

July 24, 2019

Favorable safety data announced for dose-escalation run-in of phase III INTACT study

July 24, 2019

BXCL-501 meets primary endpoint in phase Ib study for agitation associated with schizophrenia

July 24, 2019

COPD has autoimmune component

July 24, 2019

Deglycosylation predicts anti-PD-1/PD-L1 therapeutic efficacy

July 24, 2019

Inhaled alprazolam suppresses epileptiform activity in photosensitive participants with epilepsy

July 24, 2019

PROTAC design approach for targeted degradation of BAP complex ATPAses in cancer

July 24, 2019

Researchers describe cell device for pancreatic islet transplantation without immunosuppression

July 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...